Pharmapack Europe launches new Start-up Hub
31 May 2016 | By Pharmapack
Pharmapack is a two-day exhibition and conference dedicated to pharmaceutical packaging, drug delivery and affiliated industries...
List view / Grid view
News
Infliximab biosimilar Flixabi approved in the EU
31 May 2016 | By Victoria White, Digital Content Producer
The EC has granted marketing authorisation in the European Union (EU) for Flixabi, an infliximab biosimilar referencing Remicade...
MHRA approves bionic vision system clinical trial
31 May 2016 | By Victoria White, Digital Content Producer
Pixium Vision has received approval from the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK to initiate a clinical trial for patients who have lost sight due to retinitis pigmentosa (RP) with the IRIS II bionic vision system.
AbbVie tops the RepTrak ranking for most reputable pharma company in the UK
31 May 2016 | By Victoria White, Digital Content Producer
Reputation Institute has announced that AbbVie, Sanofi and Novo Nordisk top the RepTrak ranking of the most reputable pharmaceutical companies in the UK...
Jazz Pharmaceuticals to acquire Celator for $1.5 billion
31 May 2016 | By Victoria White, Digital Content Producer
The transaction advances Jazz Pharmaceuticals' growth strategy and adds Celator's investigational therapy Vyxeous to the company’s portfolio...
Eppendorf expands single-use vessel portfolio for microbial fermentation
31 May 2016 | By Eppendorf
Eppendorf's BioBLU 3f Single-Use Vessels specifically address the demands of high cell density fermentation of bacteria, yeasts and fungi...
New technique for fast low-level polymorph API quantification using non-destructive transmission Raman spectroscopy
27 May 2016 | By Cobalt Light Systems
A new technique for measuring low-levels of crystalline polymorphic materials offers many advantages over industry standard techniques....
Positive CHMP opinion for Gilead’s Epclusa in HCV
27 May 2016 | By Victoria White, Digital Content Producer
The EMA’s CHMP has adopted a positive opinion on Gilead’s Epclusa for the treatment of chronic hepatitis C virus...
Amgen receives positive CHMP opinion to extend indication of Kyprolis
27 May 2016 | By Victoria White, Digital Content Producer
The CHMP has adopted a positive opinion to extend the indication for Kyprolis to include treatment in combination with dexamethasone in multiple myeloma...
Positive CHMP opinion for Adcetris in post-transplant Hodgkin lymphoma
27 May 2016 | By Victoria White, Digital Content Producer
The opinion is for Adcetris for the treatment of adult patients with CD30+ Hodgkin lymphoma at increased risk of relapse or progression following ASCT...
Faslodex demonstrates superiority to Arimidex in Phase III study
27 May 2016 | By Victoria White, Digital Content Producer
The Phase III FALCON trial compared Faslodex to Arimidex for the treatment of locally-advanced or metastatic breast cancer, in post-menopausal women...
Stomach cancer with copies of FGFR2 gene more susceptible to AZD4547
27 May 2016 | By Victoria White, Digital Content Producer
Scientists are able to identify patients with stomach cancer who are most likely to respond to AZD4547 by measuring copies of the FGFR2 gene in the bloodstream...
CHMP positive opinion for teduglutide in paediatric patients
27 May 2016 | By Victoria White, Digital Content Producer
The CHMP has adopted a positive opinion of Shire’s Revestive (teduglutide) solution for injection in paediatric patients with short bowel syndrome...
Positive results from Phase III study of Gazyva in follicular lymphoma
27 May 2016 | By Victoria White, Digital Content Producer
Roche has announced positive results from the pivotal Phase III GALLIUM study.
Researchers develop technology for printed personalised medicine
Researchers from the National University of Singapore have found a way to make personalised medicine cheaper and easier.
